Lexaria BioscienceLEXX
13F holders, Q1 2025 (March 31)22holders −3
2new positions
5sold out
$1.71avg. 13F price*
At the end of Q1 2025, 22 institutions reported holding Lexaria Bioscience Corp. (LEXX) in their 13F filings, down 3 from Q4 2024. 2 opened new positions and 5 sold out. The largest holders were Invenomic Capital Management LP ($940K), Geode Capital Management, LLC ($295K) and Toronto Dominion Bank ($222K).
- Company
- Lexaria Bioscience Corp.
- CUSIP
- 52886N406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $223K |
| Exits | 5 | $1.0M |
All 13F filers, Q4 2024 → Q1 2025: 294,480 shares bought and 496,172 shares sold, net −201,692 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Invenomic Capital Management LP | 0.05% | Add +33.9% | 549,947 | $940K |
| Geode Capital Management, LLC | 0.00% | Add +3.5% | 172,457 | $295K |
| Toronto Dominion Bank | 0.00% | New | 130,025 | $222K |
| Vanguard Group Inc. | 0.00% | Add +0.3% | 127,871 | $219K |
| Raymond James Financial Inc. | 0.00% | Add +1.0% | 61,250 | $105K |
| State Street Corp. | 0.00% | No change | 39,301 | $67K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | Add +7.2% | 30,959 | $53K |
| Byrne Asset Management LLC | 0.04% | Add +122.3% | 28,905 | $49K |
| BlackRock, Inc. | 0.00% | No change | 27,445 | $47K |
| HighTower Advisors, LLC | 0.00% | Reduce -0.1% | 21,000 | $36K |
| Northern Trust Corp. | 0.00% | No change | 18,389 | $31K |
| Bank of Montreal | 0.00% | Add +0.2% | 14,033 | $24K |
| Royal Bank of Canada | 0.00% | No change | 7,283 | $12K |
| Oakworth Capital, Inc. | 0.00% | No change | 5,000 | $9K |
| Wells Fargo & Company | 0.00% | Reduce -50.0% | 2,000 | $3K |
| Osaic Holdings, Inc. | 0.00% | Reduce -17.5% | 1,890 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -37.7% | 1,298 | $2K |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 382 | $653 |
| Farther Finance Advisors, LLC | 0.00% | No change | 166 | $272 |
| Bank of America Corp. | 0.00% | Add +5.6% | 133 | $227 |
| Sound Income Strategies, LLC | 0.00% | No change | 22 | $38 |
| Gables Capital Management Inc. | 0.00% | No change | 13 | $22 |
"% of holder's portfolio" is LEXX's weight in each manager's 13F, not the share of Lexaria Bioscience Corp. the manager owns.